1. 1-24 of 434 1 2 3 4 ... 16 17 18 »
    1. Cara Therapeutics Expands Board of Directors with Appointment of Susan Shiff, Ph.D., M.B.A.

      Cara Therapeutics Expands Board of Directors with Appointment of Susan Shiff, Ph.D., M.B.A.

      Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors, or KORs, today announced the appointment of Susan Shiff, Ph.D., M.B.A., to its Board of Directors...

      Read Full Article
    2. Aprea Therapeutics Appoints Fouad Namouni, M.D. and Richard Peters, M.D., Ph.D. to Board of Directors

      Aprea Therapeutics Appoints Fouad Namouni, M.D. and Richard Peters, M.D., Ph.D. to Board of Directors

      Aprea Therapeutics Inc., (NASDAQ: APRE), a clinical-stage biotechnology company focused on developing and commercializing novel cancer therapeutics that reactivate mutant p53 tumor suppressor protein, today announced the appointments of Fouad Namouni, M.D. and Richard Peters, M.D., Ph.D. to its Board of Directors...

      Read Full Article
    3. Neuronetics Announces Appointment of Bruce J. Shook to its Board of Directors

      Neuronetics Announces Appointment of Bruce J. Shook to its Board of Directors

      Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced the appointment of Bruce J. Shook to its Board of Directors and as a member of the Audit Committee...

      Read Full Article
    4. FactSet Appoints Robin Abrams Chair of the Board of Directors

      FactSet Appoints Robin Abrams Chair of the Board of Directors

      FactSet (NYSE:FDS) (NASDAQ:FDS), a global provider of integrated financial information, analytical applications, and industry-leading service, announced that its Board of Directors has appointed Robin Abrams to succeed Phil Hadley as chair. FactSet also announced the appointment of two new directors, Siew Kai Choy and Lee Shavel, who will both serve as members of the Audit Committee...

      Read Full Article
    5. ADMA Biologics Announces Martha J. Demski Elected to Board of Directors

      ADMA Biologics Announces Martha J. Demski Elected to Board of Directors

      ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, today announced that the proposed resolution to elect Martha J. Demski to its Board of Directors was approved at the Company’s recent Annual Shareholder Meeting, held June 18, 2020...

      Read Full Article
    6. Peter Svennilson Elected to RAPT Therapeutics Board of Directors

      Peter Svennilson Elected to RAPT Therapeutics Board of Directors

      RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases, today announced the election of Peter Svennilson, Managing Partner of The Column Group, to its Board of Directors...

      Read Full Article
    7. Abeona Therapeutics Further Strengthens Board with Appointment of Two New Independent Directors

      Abeona Therapeutics Further Strengthens Board with Appointment of Two New Independent Directors

      Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced Board of Director appointments that strengthen and expand the Company’s leadership. George Migausky and Paul Mann were appointed as independent directors, effective June 17, 2020...

      Read Full Article
    8. Palomar Holdings, Inc. Announces Changes to its Board of Directors

      Palomar Holdings, Inc. Announces Changes to its Board of Directors

      Palomar Holdings, Inc. (NASDAQ:PLMR) today announced changes to its Board of Directors (the “Board”).  Ryan Clark, President and Managing Director of Genstar Capital, has stepped down as Chairman of the Board of Palomar effective June 17, 2020, and will no longer serve as a director, following Genstar’s disposition of its remaining ownership interests in May 2020...

      Read Full Article
    9. ContraFect Announces Appointment of Lishan Aklog, M.D. to Board of Directors

      ContraFect Announces Appointment of Lishan Aklog, M.D. to Board of Directors

      ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the treatment of life-threatening, antibiotic-resistant infections, today announced the appointment of Lishan Aklog, M.D. to the Company’s board of directors...

      Read Full Article
    10. Houston Wire & Cable Company Announces Governance, Management Changes

      Houston Wire & Cable Company Announces Governance, Management Changes

      HOUSTON, June 12, 2020 (GLOBE NEWSWIRE) -- Houston Wire & Cable Company (NASDAQ: HWCC) (the Company) today announced that Gary Yetman has been named executive chairman of the board. William H. Sheffield, who has served as non-executive chairman since 2012, will remain on the board and succeed Yetman as chairman of the Nominating and Corporate Governance Committee. Sheffield previously announced his intention to retire from the board upon expiration of his current term...

      Read Full Article
    1-24 of 434 1 2 3 4 ... 16 17 18 »
  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Question of The Week, Sponsored Content